Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 542549, 7 pages
http://dx.doi.org/10.1155/2014/542549
Research Article

Differential Effects of Dry Eye Disorders on Metabolomic Profile by 1H Nuclear Magnetic Resonance Spectroscopy

1Ophthalmic Research Unit “Santiago Grisolía”, University Hospital Doctor Peset, Avenue Gaspar Aguilar 90, 46017 Valencia, Valencia, Spain
2Ophthalmic Research Unit, Faculty of Medicine, University of Valencia, Valencia, Spain
3University and Polytechnic Hospital La Fe, Valencia, Spain
4Central Unit of Research in Medicine, University of Valencia, Valencia, Spain
5Clinical Hospital Research Foundation (INCLIVA), Valencia, Spain

Received 28 February 2014; Revised 16 April 2014; Accepted 29 April 2014; Published 21 May 2014

Academic Editor: Alfredo García-Layana

Copyright © 2014 Carmen Galbis-Estrada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Rolando and M. Zierhut, “The ocular surface and tear film and their dysfunction in dry eye disease,” Survey of Ophthalmology, vol. 45, no. 2, pp. S203–S210, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. “The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007),” Ocular Surface, vol. 5, no. 2, pp. 75–92, 2007. View at Scopus
  3. J. Murube, “Andrew de Roetth (1893—1981): dacryologist who introduced the term dry eye,” Ocular Surface, vol. 2, no. 4, pp. 225–227, 2004. View at Google Scholar · View at Scopus
  4. J. L. Gayton, “Etiology, prevalence, and treatment of dry eye disease,” Clinical Ophthalmology, vol. 3, no. 1, pp. 405–412, 2009. View at Google Scholar · View at Scopus
  5. G. N. Foulks, “Pharmacological management of dry eye in the elderly patient,” Drugs and Aging, vol. 25, no. 2, pp. 105–118, 2008. View at Google Scholar · View at Scopus
  6. S. E. Moss, R. Klein, and B. E. K. Klein, “Prevalance of and risk factors for dry eye syndrome,” Archives of Ophthalmology, vol. 118, no. 9, pp. 1264–1268, 2000. View at Google Scholar · View at Scopus
  7. H. D. Perry, “Dry eye disease: pathophysiology, classification, and diagnosis,” The American Journal of Managed Care, vol. 14, no. 3, pp. S79–S87, 2008. View at Google Scholar · View at Scopus
  8. A. Labbé, F. Brignole-Baudouin, and C. Baudouin, “Ocular surface investigations in dry eye,” Journal Francais d'Ophtalmologie, vol. 30, no. 1, pp. 76–97, 2007. View at Google Scholar · View at Scopus
  9. D. Monleón, J. M. Morales, A. Barrasa, J. A. López, C. Vázquez, and B. Celda, “Metabolite profiling of fecal water extracts from human colorectal cancer,” NMR in Biomedicine, vol. 22, no. 3, pp. 342–348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. F. Gomez-Casati, M. I. Zanor, and M. V. Busi, “Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases,” BioMed Research International, vol. 2013, Article ID 792527, 11 pages, 2013. View at Publisher · View at Google Scholar
  11. D. S. Wishart, T. Jewison, A. C. Guo et al., “HMDB: the human metabolome database,” Nucleic Acids Research, vol. 35, pp. D521–D526, 2007. View at Google Scholar
  12. V. Bodi, J. Sanchis, J. M. Morales et al., “Metabolomic profile of human myocardial ischemia by nuclear magnetic resonance spectroscopy of peripheral blood serum: a translational study based on transient coronary occlusion models,” Journal of the American College of Cardiology, vol. 59, no. 18, pp. 1629–1641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Tiziani, A.-H. Emwas, A. Lodi et al., “Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy,” Analytical Biochemistry, vol. 377, no. 1, pp. 16–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. L. D. Lehman-Mckeeman and B. D. Car, “Metabonomics: application in predictive and mechanistic toxicology,” Toxicologic Pathology, vol. 32, supplement 2, pp. 94–95, 2004. View at Google Scholar
  15. E. Holmes, R. L. Loo, J. Stamler et al., “Human metabolic phenotype diversity and its association with diet and blood pressure,” Nature, vol. 453, pp. 396–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Kaddurah-Daouk, B. S. Kristal, and R. M. Weinshilboum, “Metabolomics: a global biochemical approach to drug response and disease,” Annual Review of Pharmacology and Toxicology, vol. 48, pp. 653–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. P. Young and G. R. Wallace, “Metabolomic analysis of human disease and its application to the eye,” Journal of Ocular Biology, Diseases, and Informatics, vol. 2, no. 4, pp. 235–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. C. Lindon, E. Holmes, M. E. Bollard, E. G. Stanley, and J. K. Nicholson, “Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis,” Biomarkers, vol. 9, no. 1, pp. 1–31, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. K. Nicholson, J. C. Lindon, and E. Holmes, “‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data,” Xenobiotica, vol. 29, no. 11, pp. 1181–1189, 1999. View at Google Scholar · View at Scopus
  20. N. J. Serkova, T. J. Standiford, and K. A. Stringer, “The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses,” The American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 6, pp. 647–655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. L. M. Smith, A. D. Maher, E. J. Want et al., “Large-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation,” Analytical Chemistry, vol. 81, no. 12, pp. 4847–4856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Weckwerth and K. Morgenthal, “Metabolomics: from pattern recognition to biological interpretation,” Drug Discovery Today, vol. 10, no. 22, pp. 1551–1558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Midelfart, “Metabonomics—a new approach in ophthalmology,” Acta Ophthalmologica, vol. 87, no. 7, pp. 697–703, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. P. Young, M. Nessim, F. Falciani et al., “Metabolomic analysis of human vitreous humor differentiates ocular inflammatory disease,” Molecular Vision, vol. 15, pp. 1210–1217, 2009. View at Google Scholar · View at Scopus
  25. A. Mayordomo-Febrer, M. López-Murcia, J. M. Morales et al., “Metabolomics of the aqueous humor in glaucomatous rats,” Ophthalmic Research, vol. 50, pp. 27–53, 2013. View at Google Scholar
  26. I. A. Butovich, “On the lipid composition of human meibum and tears: comparative analysis of nonpolar lipids,” Investigative Ophthalmology and Visual Science, vol. 49, no. 9, pp. 3779–3789, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Savini, P. Prabhawasat, T. Kojima, M. Grueterich, E. Espana, and E. Goto, “The challenge of dry eye diagnosis,” Journal of Clinical Ophthalmology, vol. 2, no. 1, pp. 31–55, 2008. View at Google Scholar
  28. M. D. Pinazo-Durán, C. Galbis-Estrada, and S. Pons-Vázquez, “Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders,” Journal of Clinical Interventions in Aging, vol. 8, pp. 139–148, 2013. View at Publisher · View at Google Scholar
  29. S. V. Aluru, S. Agarwal, B. Srinivasan et al., “Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome,” PLoS ONE, vol. 7, no. 12, Article ID e51979, 2012. View at Publisher · View at Google Scholar
  30. B. Li, M. Sheng, and L. Xie, “Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry,” Investigative Ophthalmology & Visual Science, vol. 55, no. 1, pp. 177–186, 2014. View at Google Scholar
  31. M. Nakatsukasa, C. Sotozono, K. Shimbo et al., “Amino acid profiles in human tear fluids analyzed by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry,” The American Journal of Ophthalmology, vol. 151, no. 5, pp. 799.e1–808.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. R. Taormina, J. T. Baca, S. A. Asher, J. J. Grabowski, and D. N. Finegold, “Analysis of tear glucose concentration with electrospray ionization mass spectrometry,” Journal of the American Society for Mass Spectrometry, vol. 18, no. 2, pp. 332–336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Zhou and R. W. Beuerman, “Tear analysis in ocular surface diseases,” Progress in Retinal and Eye Research, vol. 31, no. 6, pp. 527–550, 2012. View at Publisher · View at Google Scholar
  34. S. Bacman, A. Berra, L. Sterin-Borda, and E. Borda, “Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome,” Investigative Ophthalmology and Visual Science, vol. 42, no. 2, pp. 321–327, 2001. View at Google Scholar · View at Scopus
  35. N. Vinayavekhin, E. A. Homan, and A. Saghatelian, “Exploring disease through metabolomics,” ACS Chemical Biology, vol. 5, no. 1, pp. 91–103, 2010. View at Publisher · View at Google Scholar · View at Scopus